Back
Ultragenyx Pharmaceutical Stock Predictions
Sponsored
RARE
Sponsored
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
7 Day Trial
ALL ACCESS PASS
$
7
Alex Green's "Next Magnificent Seven" AI Stocks-Turn $7,000 into $1 Million!
Watch Alex's presentation and discover the AI stocks set to dominate!Ultragenyx Pharmaceutical Stock Forecast
-
Is Ultragenyx Pharmaceutical Stock Undervalued?
The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal. - RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Ultragenyx Pharmaceutical Stock Go Up Next Year?
Data Unavailable
Ultragenyx Pharmaceutical Stock Rating
Data Unavailable
Ultragenyx Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ultragenyx.com
52-Week Data
52-Week High:
60.37
52-Week Low:
31.52
Prediction Charts
Market Cap:
5.02B
Price in USD:
54.43
Volume:
575.01K
Beta:
1.10
Technical Analysis
SMA50:
52.99
SMA100:
47.11
SMA200:
46.88
52-Wk Change:
47.47%
Stock Predictions
-
Is Ultragenyx Pharmaceutical stock public?
Yes, Ultragenyx Pharmaceutical is a publicly traded company. -
What is the Ultragenyx Pharmaceutical stock quote today?
The Ultragenyx Pharmaceutical stock price is 54.43 USD today. -
How to buy Ultragenyx Pharmaceutical stock online?
You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-10 | 55.94 | 55.72 | 56.53 | 55.27 |
Sep-11 | 55.53 | 56.31 | 56.54 | 54.94 |
Sep-12 | 56.18 | 57.87 | 57.98 | 56.14 |
Sep-13 | 58.00 | 58.74 | 59.76 | 58.00 |
Sep-16 | 59.37 | 59.36 | 60.37 | 58.36 |
Sep-17 | 59.32 | 58.49 | 59.56 | 57.83 |
Sep-18 | 58.72 | 57.70 | 58.96 | 57.44 |
Sep-19 | 58.54 | 58.77 | 59.90 | 58.21 |
Sep-20 | 58.78 | 58.75 | 59.09 | 57.91 |
Sep-23 | 59.17 | 57.56 | 59.50 | 57.42 |
Sep-24 | 57.52 | 57.44 | 58.14 | 56.38 |
Sep-25 | 57.60 | 56.76 | 57.78 | 56.74 |
Sep-26 | 56.99 | 55.20 | 57.13 | 55.13 |
Sep-27 | 55.44 | 54.43 | 55.44 | 54.29 |
Ultragenyx Pharmaceutical Earnings
Data Unavailable
Ultragenyx Pharmaceutical Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.